Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Sep 27;11:1758835919879026. doi: 10.1177/1758835919879026

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2019

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Decision algorithm for patients with primary mRCC of clear-cell subtype and good performance status.

AXI, axitinib; CN, cytoreductive nephrectomy; IMDC, International Metastatic Database Consortium risk model; IPI, ipilimumab; MET, metastases; mRCC, metastatic renal cell carcinoma; MTD, multidisciplinary team decision; NIVO, nivolumab; PD, progressive disease; PEMBRO, pembrolizumab; RCC, renal cell carcinoma.